|
⚲
|
| Keyboard |
| Carlo Rizzuto | |
|---|---|
| Firm | |
| Address | 11757 W Ken Caryl Avenue Suite F, 520 Littleton, CO 80127-3719 |
| Source |
| Associated Funds | Form D | Role | 2011 - 2026 | Raised | AUM |
|---|---|---|---|---|---|
| Pep2Tango Therapeutics Inc | 021-530055 | Director | 16.7 M of 16.7 M |
||
| NEXO Therapeutics Inc | 021-465438 | Director | 60.0 M of 60.0 M |
||
| Jnana Therapeutics Inc | 021-465004 | Director | 107.0 M of 107.0 M |
||
| Jnana Therapeutics Inc | 021-411066 | Director | 50.0 M of 50.0 M |
||
| 858 Therapeutics Inc | 021-399747 | Director | 20.0 M of 40.0 M |
||
| Graphite Bio Inc | 021-392907 | Director | 150.7 M of 150.7 M |
||
| Century Therapeutics Inc | 021-392334 | Director | of 160.0 M |
||
| Pandion Therapeutics HoldCo LLC | 021-364484 | Director | 40.0 M of 80.0 M |
||
| Quentis Therapeutics Inc | 021-306751 | Executive Officer | 19.7 M of 47.9 M |
||
| Pandion Therapeutics Inc | 021-303791 | Director | 21.6 M of 57.6 M |
||
| Venatorx Pharmaceuticals Inc | 021-291424 | Director | 27.1 M of 47.1 M |
||
| Versant Venture Management LLC | |||||
| Versant Vantage III LP | 021-461398 | Executive Officer | 298.7 M of 298.7 M |
295.6 M | |
| Versant Venture Capital IX LP | 021-461417 | Executive Officer | 600.4 M of 600.4 M |
586.2 M | |
| Versant Voyageurs III LP | 021-461406 | Executive Officer | 300.2 M of 300.2 M |
311.8 M | |
| Related People Network |
|---|
| Network #136 at Versant Venture Management LLC — files alongside 14 co-filers |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Century Therapeutics Inc IPSC
Stock Option (right to buy) · derivative
|
2025-06-12 | Grant | 44,000 | $0.00 | |
|
Century Therapeutics Inc IPSC
Stock Option (right to buy) · derivative
|
2024-06-20 | Grant | 44,000 | $0.00 | |
|
LENZ Therapeutics Inc GRPH
Stock Option (right to buy) · derivative
|
2023-07-19 | Grant | 20,000 | $0.00 | |
|
Century Therapeutics Inc IPSC
Stock Option (right to buy) · derivative
|
2023-06-27 | Grant | 44,000 | $0.00 | |
|
LENZ Therapeutics Inc GRPH
Stock Option (right to buy) · derivative
|
2022-06-21 | Grant | 20,000 | $0.00 | |
|
Century Therapeutics Inc IPSC
Stock Option (right to buy) · derivative
|
2022-06-09 | Grant | 19,872 | $0.00 | |
|
LENZ Therapeutics Inc GRPH
Stock Option (right to buy) · derivative
|
2021-06-24 | Grant | 40,000 | $0.00 | |
|
Century Therapeutics Inc IPSC
Option (right to buy) · derivative
|
2021-06-17 | Grant | 39,744 | $0.00 | |
|
Pandion Therapeutics Inc PAND
Employee Stock Option (Right to Buy) · derivative
|
2021-04-01 | Disposed to issuer | 13,997 | ||
|
Pandion Therapeutics Inc PAND
Stock Option (right to buy) · derivative
|
2020-07-17 | Grant | 13,997 | $0.00 |